Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial

S. Quenby, Katie Booth, Louise Hiller, A. Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, L. Scheres, T. V. van Haaps, L. Ewington, Shreeya Tewary, M. Goddijn, Saskia Middeldorp
{"title":"Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial","authors":"S. Quenby, Katie Booth, Louise Hiller, A. Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, L. Scheres, T. V. van Haaps, L. Ewington, Shreeya Tewary, M. Goddijn, Saskia Middeldorp","doi":"10.1097/01.ogx.0001006880.59476.45","DOIUrl":null,"url":null,"abstract":"(Abstracted from Lancet 2023;402:54–61)\n Inherited thrombophilia is implicated as a cause of recurrent pregnancy loss, defined as the loss of 2 or more pregnancies. Heparin is the standard treatment for acquired thrombophilia but is not recommended in cases of recurrent pregnancy loss and inherited thrombophilia.","PeriodicalId":509854,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"15 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrical & Gynecological Survey","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.ogx.0001006880.59476.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

(Abstracted from Lancet 2023;402:54–61) Inherited thrombophilia is implicated as a cause of recurrent pregnancy loss, defined as the loss of 2 or more pregnancies. Heparin is the standard treatment for acquired thrombophilia but is not recommended in cases of recurrent pregnancy loss and inherited thrombophilia.
肝素治疗复发性流产和遗传性血栓性妇女(ALIFE2):一项国际开放标签随机对照试验
(摘自《柳叶刀》2023;402:54-61)遗传性血栓性疾病是导致反复妊娠流产的原因之一,反复妊娠流产是指两次或两次以上妊娠流产。肝素是治疗获得性血栓性疾病的标准药物,但不推荐用于反复妊娠流产和遗传性血栓性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信